Last reviewed: 31 Jun 2021
Last updated: 19 May 2021

Summary

Definition

History and exam

Key diagnostic factors

  • fever
  • decreased milk outflow
  • breast warmth
  • breast tenderness
  • breast firmness
  • breast swelling
  • breast erythema
  • flu-like symptoms, malaise, and myalgia
  • breast pain
  • breast mass
  • fistula

Other diagnostic factors

  • nipple discharge
  • nipple inversion/retraction
  • lymphadenopathy
  • extra-mammary skin lesions

Risk factors

  • female sex
  • women aged >30 years
  • poor breast-feeding technique
  • lactation
  • milk stasis
  • nipple injury
  • previous mastitis
  • prolonged mastitis (breast abscess)
  • prior breast abscess (breast abscess)
  • shaving or plucking areola hair
  • anatomical breast defect, mammoplasty, or scar
  • other underlying breast condition
  • nipple piercing
  • foreign body
  • skin infection
  • Staphylococcus aureus carrier
  • immunosuppression
  • hospital admission
  • breast trauma
  • primiparity
  • overabundant milk supply
  • postmaturity (breast abscess)
  • complications of delivery
  • maternal fatigue
  • tight clothing
  • antifungal nipple cream
  • fibrocystic breast disease
  • cigarette smoking
  • vaginal manipulation (breast abscess)
  • poor nutrition
  • antiretroviral therapy

Diagnostic investigations

1st investigations to order

  • breast ultrasound
  • diagnostic needle aspiration drainage
  • cytology of nipple discharge or sample from fine-needle aspiration
  • milk, aspirate, discharge, or biopsy tissue for culture and sensitivity
  • histopathologic examination of biopsy tissue

Investigations to consider

  • pregnancy test
  • blood culture and sensitivity
  • mammogram
  • milk for leukocyte counts and bacteria quantification
  • CBC
  • tuberculin skin test (purified protein derivative)

Treatment algorithm

Contributors

Authors

Holly S. Mason, MD, FACS
Holly S. Mason

Assistant Professor of Surgery

University of Massachusetts Medical School - Baystate

Springfield

MA

Disclosures

HSM declares that she has no competing interests.

Acknowledgements

Dr Holly S. Mason would like to gratefully acknowledge Dr Jose A. Martagon-Villamil, Dr Daniel Skiest, Dr Gina Berthold, and Dr Liron Pantanowitz, previous contributors to this topic.

Disclosures

JAMV, DS, and GB declare that they have no competing interests. LP is a co-author of references cited in this topic.

Peer reviewers

Edward Sauter, MD, PhD

Program Officer

National Institutes of Health

National Cancer Institute

Rockville

MD

Disclosures

ES declares that he has no competing interests.

Justin Stebbing, MA, MRCP, MRCPath, PhD

Consultant Medical Oncologist/Senior Lecturer

Department of Medical Oncology

Imperial College/Imperial Healthcare NHS Trust

Charing Cross Hospital

London

UK

Disclosures

JS declares that he has no competing interests.

William C. Dooley, MD

The G. Rainey Williams Professor of Surgical Oncology

University of Oklahoma

Oklahoma City

OK

Disclosures

WD declares that he has no competing interests.

Use of this content is subject to our disclaimer